Drug Database
Back to search

Netherlands· NL-f46a61d23b76

Odefsey 200 mg/25 mg/25 mg filmomhulde tabletten

A emtricitabine, tenofovir alafenamide and rilpivirine product containing emtricitabine + rilpivirinehydrochloride + tenofoviralafenamidefumaraat, registered in Netherlands by Gilead Sciences Ireland UC. The same ATC class is registered in 13 of our 19 countries.

ATC J05AR19

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedOdefsey 200 mg/25 mg/25 mg filmomhuld…ATCJ05AR19REGISTER NO.NL-f46a61d23b76PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about emtricitabine + rilpivirinehydrochloride + tenofoviralafenamidefumaraatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Emtricitabine, tenofovir alafenamide and rilpivirine is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AR19 (emtricitabine, tenofovir alafenamide and rilpivirine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search emtricitabine, tenofovir alafenamide and rilpivirine products by name

Emtricitabine, tenofovir alafenamide and rilpivirine · ATC J05AR19

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
EMTRICITABINE + RILPIVIRINEHYDROCHLORIDE + TENOFOVIRALAFENAMIDEFUMARAAT
Manufacturer
Gilead Sciences Ireland UC
Country
Netherlands (NL)
ATC code
J05AR19
ATC class
Emtricitabine, tenofovir alafenamide and rilpivirine
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/16/1112

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under J05AR19

Emtricitabine, tenofovir alafenamide and rilpivirine, as other registers publish it.

All emtricitabine, tenofovir alafenamide and rilpivirine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c817a3c8-a972-4039-9a75-8d472335064b
GET /v1/drugs/c817a3c8-a972-4039-9a75-8d472335064b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/odefsey-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Emtricitabine, tenofovir alafenamide and rilpivirine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp117877",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "IJZEROXIDE ZWART (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 3350",
    "MAGNESIUMSTEARAAT (E 470b)",
    "POLYSORBAAT 20 (E 432)",
    "POLYVINYLALCOHOL, GEDEELTELIJK GEHYDROLYSEERD (E1203)",
    "POVIDON (E 1201)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "EMTRICITABINE",
    "RILPIVIRINEHYDROCHLORIDE",
    "TENOFOVIRALAFENAMIDEFUMARAAT"
  ],
  "leaflet_url": null,
  "authorised_at": "2016/06/21",
  "procedure_number": "EMEA/H/C/004156",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/16/1112",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about emtricitabine, tenofovir alafenamide and rilpivirine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console